Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022

SELL
$1.24 - $2.75 $34,220 - $75,891
-27,597 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$2.42 - $3.65 $24,461 - $36,894
10,108 Added 57.8%
27,597 $69,000
Q3 2021

Nov 12, 2021

SELL
$2.82 - $3.7 $83,393 - $109,416
-29,572 Reduced 62.84%
17,489 $56,000
Q2 2021

Aug 12, 2021

BUY
$3.5 - $5.48 $14,255 - $22,320
4,073 Added 9.47%
47,061 $168,000
Q1 2021

May 03, 2021

SELL
$3.16 - $4.89 $13,919 - $21,540
-4,405 Reduced 9.29%
42,988 $152,000
Q4 2020

Feb 12, 2021

BUY
$2.2 - $4.45 $19,927 - $40,308
9,058 Added 23.63%
47,393 $150,000
Q2 2020

Aug 10, 2020

BUY
$1.83 - $3.16 $70,153 - $121,138
38,335 New
38,335 $102,000
Q3 2018

Nov 14, 2018

SELL
$1.44 - $3.13 $2,684 - $5,834
-1,864 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$2.92 - $5.1 $82,227 - $143,616
-28,160 Reduced 93.79%
1,864 $6,000
Q1 2018

May 15, 2018

BUY
$3.42 - $5.35 $74,528 - $116,587
21,792 Added 264.72%
30,024 $136,000
Q4 2017

Feb 08, 2018

SELL
$3.26 - $4.84 $3,667 - $5,445
-1,125 Reduced 12.02%
8,232 $33,000
Q3 2017

Nov 14, 2017

BUY
$3.83 - $4.89 $35,837 - $45,755
9,357
9,357 $41,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $189M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.